Osteomyelitis clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18-85
This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.
Our lead scientists for Osteomyelitis research studies include Ashley Miller, MD.